Form 6-K

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CI&T Inc Investors to Inquire About Securities Class Action Investigation – CINT

Retrieved on: 
Samstag, Mai 25, 2024
Titan, News, Bank statement, CI&T, Advertising, Annual report, Form 6-K, Cryptocurrency

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23854 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Tritium Will Not Appeal Nasdaq Delisting Determination

Retrieved on: 
Donnerstag, Mai 23, 2024
Corporation, Security (finance), Exchange, The Act, KPMG, Letter, Administrator, Receiver, Act, Management, OTC, File, Form 6-K, FINRA, Cryptocurrency

The powers of the directors of the Companies are suspended during the administration period.

Key Points: 
  • The powers of the directors of the Companies are suspended during the administration period.
  • Such letter provided that the foregoing actions were in accordance with Nasdaq Listing rules 5101, 5110(b) and IM-5101-1.
  • Such letters further requested that the Company’s securities be placed in a trading halt immediately and until further notice.
  • The Company does not intend to appeal or otherwise challenge the Staff’s determination to delist the Company’s securities from Nasdaq.

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord

Retrieved on: 
Mittwoch, Mai 22, 2024
Cayman Islands, Petition, News, Advertising, Joint, Transaction, OTC, Defendant, Form 6-K, LLP, Court

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Global Cord’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
  • To learn more about the Global Cord Blood class action, go to www.faruqilaw.com/CORBF or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages CI&T Inc Investors to Inquire About Securities Class Action Investigation – CINT

Retrieved on: 
Dienstag, Mai 21, 2024
Titan, News, Bank statement, CI&T, Advertising, Annual report, Form 6-K, Cryptocurrency

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23854 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23854 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, A TOP RANKED LAW FIRM, Encourages CI&T Inc Investors to Inquire About Securities Class Action Investigation – CINT

Retrieved on: 
Samstag, Mai 18, 2024
Titan, News, Bank statement, CI&T, Advertising, Annual report, Form 6-K, Cryptocurrency

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23854 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23854 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

PainReform Provides Business Update for the First Quarter of 2024

Retrieved on: 
Mittwoch, Mai 15, 2024
Patient, IVR, Research, TEL, Form 6-K, Therapy, Pharmaceutical industry

TEL AVIV, Israel, May 15, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the first quarter ended March 31, 2024.

Key Points: 
  • TEL AVIV, Israel, May 15, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the first quarter ended March 31, 2024.
  • Importantly, we recently reached the 50% enrollment target for the second part of Phase 3 clinical trial of PRF-110 in bunionectomy.
  • In total, over 200 patients have been enrolled at eight clinical sites across the U.S.
  • As of March 31, 2024, the Company had cash and cash equivalents of $4.3 million.

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages CI&T Inc Investors to Inquire About Securities Class Action Investigation – CINT

Retrieved on: 
Mittwoch, Mai 15, 2024
Titan, News, Bank statement, CI&T, Advertising, Annual report, Form 6-K, Cryptocurrency

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23854 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Sportradar Reports First Quarter 2024 Financial and Operating Results

Retrieved on: 
Mittwoch, Mai 15, 2024
Partnership, Share repurchase, ATP, Total revenue, Tennis, Customer, World Games, Esports, Sport, Growth, NBA, Form 6-K, CBA, Annual report, UTR, Odds, Adjustment, Webcast, Computer vision

ST. GALLEN, Switzerland, May 15, 2024 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company focused on creating immersive experiences for sports fans and bettors, today announced financial results for its first quarter ended March 31, 2024.

Key Points: 
  • Sportradar made Fast Company’s 2024 list of Most Innovative Companies in sports for the Company’s leading Computer Vision technology and Enhanced Table Tennis solution.
  • Total Revenue for the current quarter was €265.9 million, up 28% year-over-year driven by growth across the portfolio, in particular Betting Technology & Solutions.
  • As a percentage of total company revenues, Betting Technology & Solutions represented 82% of total company revenue in the current quarter as compared to 78% in the prior year quarter.
  • Sportradar will host a conference call to discuss the first quarter 2024 results today, May 15, 2024, at 8:30 a.m. Eastern Time.

Nordic American Tankers Ltd (NYSE: NAT) – 1Q 2024 Earnings Report

Retrieved on: 
Dienstag, Mai 14, 2024
Insurance, Security (finance), Legislation, Accident, Petroleum, Form 6-K, Prospectus, Annual report, Record

The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business.

Key Points: 
  • The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business.
  • Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts.
  • The words “believe,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “plan,” “potential,” “will,” “may,” “should,” “expect,” “pending” and similar expressions identify forward-looking statements.
  • We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

Retrieved on: 
Montag, Mai 13, 2024
Science, Neurology, Biotechnology, Research, Pharmaceutical, Managed Care, Health, Clinical Trials, Patient, Plaque, Amyloid beta, Safety, Form, Form 6-K, Head, Brain, AC, Hart–Scott–Rodino Antitrust Improvements Act, MRCP, Down syndrome, Multimedia, ABATE, Pharmaceutical industry

Takeda ( TSE:4502/NYSE:TAK ) and AC Immune SA (NASDAQ: ACIU) today announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta (Abeta), including ACI-24.060 for the treatment of Alzheimer’s disease.

Key Points: 
  • Takeda ( TSE:4502/NYSE:TAK ) and AC Immune SA (NASDAQ: ACIU) today announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta (Abeta), including ACI-24.060 for the treatment of Alzheimer’s disease.
  • By inducing plaque clearance and efficiently inhibiting plaque formation in the brain, ACI-24.060 has the potential to delay or slow Alzheimer’s disease progression.
  • “At Takeda, we are committed to tackling some of society’s most debilitating illnesses, including Alzheimer’s disease.
  • Further details related to the agreement are available in the Form 6-K filed today by AC Immune with the U.S. Securities and Exchange Commission (SEC).